Eric Meldrum

Company: Citryll Therapeutics

Job title: Chief Scientific Officer

Seminars:

Panel Discussion: Strategic Considerations for Clinical Success in Hidradenitis Suppurativa 9:30 am

Explore how leading developers are balancing the need for regulatory-aligned endpoints with endpoints that demonstrate value to payers and patients  Debate strategies for designing more efficient trials through novel endpoint combinations and timing of assessments to accelerate development timelines  Understand different approaches to generating compelling evidence packages that support both regulatory approval and market access…Read more

day: Day Two